Jul
2026
QSNCC, Bangkok, Thailand
Visit us
stand E16
Zone

CAREGEN CO.,LTD

Exhibitor at CPHI South East Asia 2026
About Us

Caregen is a publicly listed global leader in peptide biotechnology, headquartered in South Korea. Since 2001, the company has focused on advancing human health through peptide innovation, developing over 1,800 proprietary peptides and securing more than 860 global patents across pharmaceuticals, nutraceuticals, medical aesthetics, and cosmeceuticals.
Guided by its philosophy, “We don’t just add years, we redesign longevity,” Caregen is committed to scientific integrity, proven efficacy, and clinically validated peptide innovation.

Read more Show less
Products
Show more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Korea, Republic Of
  • Founded:
    2001
  • On CPHI since:
    2016
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
Biopharmaceutical company
Consumer Goods
Distributor/Import Export
Drug delivery device Supplier/Manufacturer
Manufacturer/Innovator
OTC
Other
Primary activities
API Producer
Biopharmaceutical
Cosmeceuticals
Cosmetic Ingredients
Nutraceuticals
OTC
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
View company profile
Contact info
  • +82-2-2136-3800
  • Website
  • 23, Yeoksam-ro 98-gil, Gangnam-gu, 06188, Seoul, Republic of Korea, Korea, Republic Of
Show contact info Hide contact info
Event information
CPHI South East Asia 2026
  • 08 Jul 2026 - 10 Jul 2026
  • QSNCC, Bangkok, Thailand
  • Visit us at stand E16

Products Featured at CPHI South East Asia 2026

  • CG-P5

    Product CG-P5

    First-in-Class VEGFR2-Inhibiting Peptide Eye Drop for Wet Age-Related Macular Degeneration

    Product Overview: A New Standard for Non-Invasive Retinal Therapy
    CG-P5 is a first-in-class VEGFR2-inhibiting biomimetic peptide developed as a topical eye drop for the treatment of wet age-related m...
  • CG-T1

    Product CG-T1

    Peptide-Based Topical Therapeutic for Dry Eye Disease (DED)

    Product Overview: A Restorative Approach to Dry Eye Disease

    CG-T1 is a next-generation peptide-based topical therapy for dry eye disease, advancing toward Phase 2 clinical development in the United States following successfu...
  • Korglutide

    Product Korglutide

    Korglutide is a next-generation oral dual GLP-1R/IGF-1R peptide designed to support safe and muscle-preserving weight loss as a non-injectable nutraceutical alternative.
    Product Overview
    Korglutide is a synthetic dual GLP-1R and IGF-1R agonist peptide developed by Caregen for weight management and ...
  • MyoKi

    Product MyoKi

    MyoKi is an oral anti-myostatin peptide designed to support muscle mass and strength, enabling safe and effective muscle health management across all age groups.

    Product OverviewMyoKi is a peptide-based nutraceutical developed to support muscle preservation and functional performance t...
  • ProGsterol

    Product ProGsterol

    ProGsterol is an oral peptide-based nutraceutical designed to improve insulin receptor sensitivity and regulate glucose metabolism, supporting overall metabolic balance.
    Product Overview
    ProGsterol is a peptide-based nutraceutical developed by Caregen for metabolic disorders, including insulin re...

Caregen Co.,Ltd. Resources (1)